Paxlovid
As listed in the register: Paxlovid, Filmtabletten
·
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Nirmatrelvirum + Ritonavirum
- Made by
- Pfizer AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Behandlung der Coronavirus-Krankheit 2019 (COVID-19) bei pädiatrischen Patienten ab 6 Jahren mit einem Körpergewicht von mindestens 20 kg, die keine Sauerstofftherapie oder Hospitalisierung aufgrund von COVID-19 benötigen und bei denen ein erhöhtes Risiko für einen schweren Verlauf von COVID-19 besteht.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Pfizer AG |
|---|---|
| Active substance | Nirmatrelvirum + Ritonavirum |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J05AE30 · Antibiotics, antivirals and antifungals taken into the body |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Paxlovid, Filmtabletten |
| Packs | 30 Tablette(n) |
| Zulassungsnummer | 68793 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.